Immune Pharmaceuticals Inc. is a biotechnology company based in New York, New York, specializing in the development and advancement of innovative therapeutic solutions. Located at 708 3rd Avenue, this company operates within the vibrant biotech sector of the city, contributing to research and development efforts aimed at addressing complex medical challenges. Their focus lies in leveraging cutting-edge science to discover and develop novel treatments that have the potential to impact patient care significantly.
As a biotechnology company, Immune Pharmaceuticals Inc. engages in a range of scientific activities, including molecular biology, immunology, and pharmaceutical research. The company’s work often involves collaboration with other research institutions and industry partners to push forward the boundaries of medical science. By focusing on immunotherapy and related technologies, they aim to create therapies that harness the body’s immune system to fight diseases more effectively.
Situated in the heart of New York City, Immune Pharmaceuticals Inc. benefits from proximity to leading academic centers and a robust network of biotech enterprises. This location supports a dynamic environment for innovation and access to specialized resources. The company’s operations encompass various stages of drug discovery and development, emphasizing the translation of scientific discoveries into viable medical products.
With a contact number of 646-937-1941, Immune Pharmaceuticals Inc. maintains communication channels for inquiries related to their scientific endeavors and potential partnerships. Their presence in the biotechnology landscape of New York positions them as a notable participant in efforts to advance healthcare through biotechnological innovation.


































